A critical breakthrough in cancer investigation is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This crucial tumor suppressor protein is frequently disabled in various types of tumors, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research